Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral Bioavailability

被引：24

作者：

Hicken, Erik J. ^{[1
]}

Marmsater, Fred P. ^{[1
]}

Munson, Mark C. ^{[1
]}

Schlachter, Stephen T. ^{[1
]}

Robinson, John E. ^{[1
]}

Allen, Shelley ^{[1
]}

Burgess, Laurence E. ^{[1
]}

DeLisle, Robert Kirk ^{[1
]}

Rizzi, James P. ^{[1
]}

Topalov, George T. ^{[1
]}

Zhao, Qian ^{[1
]}

Hicks, Julie M. ^{[1
]}

Kallan, Nicholas C. ^{[1
]}

Tarlton, Eugene ^{[1
]}

Allen, Andrew ^{[1
]}

Callejo, Michele ^{[1
]}

Cox, April ^{[1
]}

Rana, Sumeet ^{[1
]}

Klopfenstein, Nathalie ^{[1
]}

Woessner, Richard ^{[1
]}

Lyssikatos, Joseph P. ^{[1
]}

机构：

[1] Array BioPharma, Dept Drug Discovery, Boulder, CO 80301 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2014年 / 5卷 / 01期

关键词：

Platelet-derived growth factor; fluoro-piperidine; fluorine; Pgp; RECEPTOR; INHIBITORS; FLUORINATION; ARYLATION; ALPHA;

D O I：

10.1021/ml4003953

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The in silico construction of a PDGFR beta kinase homology model and ensuing medicinal chemistry guided by molecular modeling, led to the identification of potent, small molecule inhibitors of PDGFR Subsequent exploration of structure-activity relationships (SAR) led to the incorporation of a constrained secondary amine to enhance selectivity. Further refinements led to the integration of a fluorine substituted piperidine, which resulted M significant reduction of P-glycoprotein (Pgp) mediated efflux and improved bioavailability. Compound 28 displayed oral exposure in rodents and had a pronounced effect in a pharmacokinetic-pharmacodynamic (PKPD) assay.

引用

页码：78 / 83

页数：6

共 50 条

[1] Synthesis of novel imidazo[1,2-a]pyridines with potent activity against herpesviruses
Gudmundsson, KS
Johns, BA
ORGANIC LETTERS, 2003, 5 (08) : 1369 - 1372
[2] Imidazo[1,2-a]pyridines with potent activity against herpesviruses
Gudmundsson, Kristian S.
Johns, Brian A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (10) : 2735 - 2739
[3] Discovery of imidazo[1,2-a]pyridines as potent MCH1R antagonists
Kishino, Hiroyuki
Moriya, Minoru
Sakuraba, Shunji
Sakamoto, Toshihiro
Takahashi, Hidekazu
Suzuki, Takao
Moriya, Ryuichi
Ito, Masahiko
Iwaasa, Hisashi
Takenaga, Norihiro
Ishihara, Akane
Kanatani, Akio
Sato, Nagaaki
Fukami, Takehiro
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4589 - 4593
[4] Synthesis and cytotoxic activity of novel imidazo[1,2-a]pyridines and quinolines
Vilchis-Reyes, M. A.
Martinez-Urbina, M. A.
Torres, E. Diaz
Guzman Sanchez, A.
EJC SUPPLEMENTS, 2008, 6 (09): : 139 - 139
[5] Synthesis and antiviral activity of imidazo[1,2-a]pyridines
Lhassani, M
Chavignon, O
Chezal, JM
Teulade, JC
Chapat, JP
Snoeck, R
Andrei, G
Balzarini, J
De Clercq, E
Gueiffier, A
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1999, 34 (03) : 271 - 274
[6] Phospharylated imidazo[1,2-a]pyridines
Tolmachev, AA
Yurchenko, AA
Kozlov, ES
Merkulov, AS
Semenova, MG
Pinchuk, AM
HETEROATOM CHEMISTRY, 1995, 6 (05) : 419 - 432
[7] DIASTEREOISOMERIC IMIDAZO[1,2-A]PYRIDINES
KUBIK, R
NEMECEK, J
BOHM, S
HRADILEK, M
KUTHAN, J
MENDELEEV COMMUNICATIONS, 1995, (01) : 29 - 30
[8] Photoisomerization of imidazo[1,2-a]pyridines
Kubik, R
Bohm, S
Havlicek, V
Kuthan, J
MENDELEEV COMMUNICATIONS, 1996, (06) : 225 - 226
[9] SYNTHESIS OF IMIDAZO[1,2-A]PYRIDINES DIRECTLY FROM METHYLKETONES OR METHYLENEKETONES - IODATION OF IMIDAZO[1,2-A]PYRIDINES
SALDABOL, NO
HILLER, SA
KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII, 1976, (10): : 1396 - 1405
[10] IMIDAZO[1,2-A]PYRIDINES .2. OZONOLYSIS OF IMIDAZO[1,2-A]PYRIDINES AND SYNTHESIS OF CARDIOTONIC AGENTS
YAMANAKA, M
SUDA, S
YONEDA, N
OHHARA, H
CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, 40 (03) : 666 - 674

← 1 2 3 4 5 →